PreprintArticleVersion 1Preserved in Portico This version is not peer-reviewed
The Link between Gut Microbiome, Nutraceuticals, Diet, and Diabetes Mellitus: A Bibliometric and Visual Analysis of Research and Emerging Trends from 2012 to 2022
Version 1
: Received: 31 December 2023 / Approved: 2 January 2024 / Online: 2 January 2024 (07:49:41 CET)
How to cite:
Sarkar, A.; Sher Khan, A.; Kaul, R.; Lee, S.; Kamal, I.; Paul, P.; Laws, S.; Chaari, A. The Link between Gut Microbiome, Nutraceuticals, Diet, and Diabetes Mellitus: A Bibliometric and Visual Analysis of Research and Emerging Trends from 2012 to 2022. Preprints2024, 2024010048. https://doi.org/10.20944/preprints202401.0048.v1
Sarkar, A.; Sher Khan, A.; Kaul, R.; Lee, S.; Kamal, I.; Paul, P.; Laws, S.; Chaari, A. The Link between Gut Microbiome, Nutraceuticals, Diet, and Diabetes Mellitus: A Bibliometric and Visual Analysis of Research and Emerging Trends from 2012 to 2022. Preprints 2024, 2024010048. https://doi.org/10.20944/preprints202401.0048.v1
Sarkar, A.; Sher Khan, A.; Kaul, R.; Lee, S.; Kamal, I.; Paul, P.; Laws, S.; Chaari, A. The Link between Gut Microbiome, Nutraceuticals, Diet, and Diabetes Mellitus: A Bibliometric and Visual Analysis of Research and Emerging Trends from 2012 to 2022. Preprints2024, 2024010048. https://doi.org/10.20944/preprints202401.0048.v1
APA Style
Sarkar, A., Sher Khan, A., Kaul, R., Lee, S., Kamal, I., Paul, P., Laws, S., & Chaari, A. (2024). The Link between Gut Microbiome, Nutraceuticals, Diet, and Diabetes Mellitus: A Bibliometric and Visual Analysis of Research and Emerging Trends from 2012 to 2022. Preprints. https://doi.org/10.20944/preprints202401.0048.v1
Chicago/Turabian Style
Sarkar, A., Sa'ad Laws and Ali Chaari. 2024 "The Link between Gut Microbiome, Nutraceuticals, Diet, and Diabetes Mellitus: A Bibliometric and Visual Analysis of Research and Emerging Trends from 2012 to 2022" Preprints. https://doi.org/10.20944/preprints202401.0048.v1
Abstract
The increasing prevalence of diabetes mellitus (DM) worldwide is a cause for global concern. Recent evidence suggests that the interaction between one’s diet and the gut microbiome are key modifiers of diabetes, highlighting the potential role of microbiome-modulating nutraceuticals. This bibliometric analysis examines literature published between 2012 and 2022 to explore trends in the latest research, with additional discussion on major takeaways and future directions. We selected and analyzed 640 articles from an initial pool of 4,099 from the Web of Science using Microsoft Excel 2016 and VOSviewer software (version 1.6.19). Our exploration covered the most common journals, countries, study designs, experimental subjects, types of DM, organisms and nutraceuticals studied, and the most cited articles. We also evaluated the most cited publications in terms of journals, organizations, and countries, along with the collaborative networks among authors, organizations and countries, and the co-occurrence of author keywords from the selection. It is evident from the increasing number of publications each year that this field has attracted growing attention over the last decade. Nonetheless, continued research is essential to sustain this trend. Our overarching study of diabetes research marks steady progress in understanding the role of—and potentially discovering applications of—microbiome modulation to enhance metabolic pathways and health outcomes. Advancements in this field may lead to potential therapeutic applications for specific diets and nutraceuticals that modulate the gut microbiota in DM.
Keywords
T2DM; gut microbiota; diet; probiotics; prebiotics; bibliometrics
Subject
Public Health and Healthcare, Other
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
,
*
